Early virologic response to сеpeginterferon alfa-2b in combination with ribavirin in treatment of patients with chronic hepatitis C

Early virologic response to сеpeginterferon alfa-2b in combination with ribavirin in treatment of patients with chronic hepatitis C

Algeron (cepeginterferon alfa-2b) is a new pegylated form of interferon alfa containing linear polyethylene glycol (molecular weight 20 kDa). Pharmacokinetic profile of Algeron allows once weekly administration. In phase II–III study 150 treatment-naive patients with compensated liver function were...

Full description

Saved in:
Bibliographic Details
Main Authors: O. O. Znoyko, M. V. Maevskaya, E. A. Klimova, S. L. Maksimov, S. N. Kizhlo, N. A. Petrochenkova, F. I. Nagimova, R. A. Ivanov, Yu. N. Linkova, T. V. Chernovskaya
Format: Article
Language:Russian
Published: Journal Infectology 2014-09-01
Series:Журнал инфектологии
Subjects:
chronic hepatitis c
treatment
early virologic response
pegylated interferon alfa
cepeginterferon alfa-2b
algeron
Online Access:https://journal.niidi.ru/jofin/article/view/158
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://journal.niidi.ru/jofin/article/view/158

Similar Items